BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35076361)

  • 21. Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.
    Musliner KL; Krebs MD; Albiñana C; Vilhjalmsson B; Agerbo E; Zandi PP; Hougaard DM; Nordentoft M; Børglum AD; Werge T; Mortensen PB; Østergaard SD
    Am J Psychiatry; 2020 Oct; 177(10):936-943. PubMed ID: 32660297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study.
    Trotta A; Iyegbe C; Di Forti M; Sham PC; Campbell DD; Cherny SS; Mondelli V; Aitchison KJ; Murray RM; Vassos E; Fisher HL
    PLoS One; 2016; 11(9):e0163319. PubMed ID: 27648571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia.
    Lin BD; Pinzón-Espinosa J; Blouzard E; van der Horst MZ; Okhuijsen-Pfeifer C; van Eijk KR; Guloksuz S; Peyrot WJ; Luykx JJ;
    JAMA Psychiatry; 2023 Feb; 80(2):181-185. PubMed ID: 36542388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study.
    Sideli L; Aas M; Quattrone D; La Barbera D; La Cascia C; Ferraro L; Alameda L; Velthorst E; Trotta G; Tripoli G; Schimmenti A; Fontana A; Gayer-Anderson C; Stilo S; Seminerio F; Sartorio C; Marrazzo G; Lasalvia A; Tosato S; Tarricone I; Berardi D; D'Andrea G; ; Arango C; Arrojo M; Bernardo M; Bobes J; Sanjuán J; Santos JL; Menezes PR; Del-Ben CM; Jongsma HE; Jones PB; Kirkbride JB; Llorca PM; Tortelli A; Pignon B; de Haan L; Selten JP; Van Os J; Rutten BP; Bentall R; Di Forti M; Murray RM; Morgan C; Fisher HL
    Soc Psychiatry Psychiatr Epidemiol; 2023 Oct; 58(10):1573-1580. PubMed ID: 37335320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactive effects of polygenic risk and cognitive subtype on brain morphology in schizophrenia spectrum and bipolar disorders.
    Quidé Y; Watkeys OJ; Girshkin L; Kaur M; Carr VJ; Cairns MJ; Green MJ
    Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1205-1218. PubMed ID: 35792918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not.
    Aas M; Melle I; Bettella F; Djurovic S; Le Hellard S; Bjella T; Ringen PA; Lagerberg TV; Smeland OB; Agartz I; Andreassen OA; Tesli M
    Psychol Med; 2018 Jan; 48(1):43-49. PubMed ID: 28967348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polygenic Risk and Episode Polarity Among Individuals With Bipolar Disorder.
    Hasseris S; Albiñana C; Vilhjalmsson BJ; Mortensen PB; Østergaard SD; Musliner KL
    Am J Psychiatry; 2023 Mar; 180(3):200-208. PubMed ID: 36651623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia.
    Ahangari M; Bustamante D; Kirkpatrick R; Nguyen TH; Verrelli BC; Fanous A; Kendler KS; Webb BT; Bacanu SA; Riley BP
    Br J Psychiatry; 2023 Jul; 223(1):301-308. PubMed ID: 36503694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic liability in individuals at ultra-high risk of psychosis: A comparison study of 9 psychiatric traits.
    Lim K; Lam M; Huang H; Liu J; Lee J
    PLoS One; 2020; 15(12):e0243104. PubMed ID: 33264322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.
    Zhang JP; Robinson D; Yu J; Gallego J; Fleischhacker WW; Kahn RS; Crespo-Facorro B; Vazquez-Bourgon J; Kane JM; Malhotra AK; Lencz T
    Am J Psychiatry; 2019 Jan; 176(1):21-28. PubMed ID: 30392411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mismatch negativity and polygenic risk scores for schizophrenia and bipolar disorder.
    Pentz AB; O'Connel KS; van Jole O; Timpe CMF; Slapø NB; Melle I; Lagerberg TV; Steen NE; Westlye LT; Haukvik UK; Moberget T; Jönsson EG; Andreassen OA; Elvsåshagen T
    Schizophr Res; 2024 Feb; 264():314-326. PubMed ID: 38215567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric Polygenic Risk Scores Across Youth With Bipolar Disorder, Youth at High Risk for Bipolar Disorder, and Controls.
    Jiang X; Zai CC; Dimick MK; Kennedy JL; Young LT; Birmaher B; Goldstein BI
    J Am Acad Child Adolesc Psychiatry; 2024 Feb; ():. PubMed ID: 38340895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide DNA methylation risk scores for schizophrenia derived from blood and brain tissues further explain the genetic risk in patients stratified by polygenic risk scores for schizophrenia and bipolar disorder.
    Ohi K; Shimada M; Soda M; Nishizawa D; Fujikane D; Takai K; Kuramitsu A; Muto Y; Sugiyama S; Hasegawa J; Kitaichi K; Ikeda K; Shioiri T
    BMJ Ment Health; 2024 Jan; 27(1):. PubMed ID: 38216218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study.
    van Os J; Pries LK; Delespaul P; Kenis G; Luykx JJ; Lin BD; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Cankurtaran EŞ; Kaymak SU; Mihaljevic MM; Petrovic SA; Mirjanic T; Bernardo M; Cabrera B; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Saka MC; ; Arango C; O'Donovan M; Rutten BPF; Guloksuz S
    Psychol Med; 2020 Aug; 50(11):1884-1897. PubMed ID: 31414981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth.
    Birmaher B; Hafeman D; Merranko J; Zwicker A; Goldstein B; Goldstein T; Axelson D; Monk K; Hickey MB; Sakolsky D; Iyengar S; Diler R; Nimgaonkar V; Uher R
    JAMA Psychiatry; 2022 Feb; 79(2):160-168. PubMed ID: 34935868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia polygenic risk score influence on white matter microstructure.
    Simões B; Vassos E; Shergill S; McDonald C; Toulopoulou T; Kalidindi S; Kane F; Murray R; Bramon E; Ferreira H; Prata D
    J Psychiatr Res; 2020 Feb; 121():62-67. PubMed ID: 31770658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polygenic risk scores and the prediction of onset of mood and psychotic disorders in adolescents and young adults.
    Scott J; Crouse JJ; Medland S; Byrne E; Iorfino F; Mitchell B; Gillespie NA; Martin N; Wray N; Hickie IB
    Early Interv Psychiatry; 2024 Jun; 18(6):397-405. PubMed ID: 37787636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.
    Schubert KO; Thalamuthu A; Amare AT; Frank J; Streit F; Adl M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Marie-Claire C; Cearns M; Cervantes P; Chen HC; Chillotti C; Cichon S; Clark SR; Cruceanu C; Czerski PM; Dalkner N; Dayer A; Degenhardt F; Del Zompo M; DePaulo JR; Étain B; Falkai P; Forstner AJ; Frisen L; Frye MA; Fullerton JM; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Grof P; Hashimoto R; Hauser J; Heilbronner U; Herms S; Hoffmann P; Hou L; Hsu YH; Jamain S; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Ferensztajn-Rochowiak E; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Maj M; ; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Ösby U; Papiol S; Pfennig A; Pisanu C; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shekhtman T; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Tekola-Ayele F; Tortorella A; Turecki G; Veeh J; Vieta E; Witt SH; Roberts G; Zandi PP; Alda M; Bauer M; McMahon FJ; Mitchell PB; Schulze TG; Rietschel M; Baune BT
    Transl Psychiatry; 2021 Nov; 11(1):606. PubMed ID: 34845190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward incorporating genetic risk scores into symptom networks of psychosis.
    Isvoranu AM; Guloksuz S; Epskamp S; van Os J; Borsboom D;
    Psychol Med; 2020 Mar; 50(4):636-643. PubMed ID: 30867074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors, Clinical Features, and Polygenic Risk Scores in Schizophrenia and Schizoaffective Disorder Depressive-Type.
    Dennison CA; Legge SE; Hubbard L; Lynham AJ; Zammit S; Holmans P; Cardno AG; Owen MJ; O'Donovan MC; Walters JTR
    Schizophr Bull; 2021 Aug; 47(5):1375-1384. PubMed ID: 33837784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.